相关实验视频
Updated: Jul 5, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
119
利用微生物组:关于促进类风湿性疾病治疗策略的全面审查
Priyadarshini Bhattacharjee1,2, Karim Arif Karim3, Zahid Khan4,5,6,7
1Acute Medicine, Cambridge University Hospital NHS Foundation Trust, Cambridge, GBR.
Cureus
|January 22, 2024
概括
微生物组,包括口腔和肠道细菌,可能会影响类风湿性疾病. 了解这些微生物群落为诸如类风湿性关节炎等疾病提供了新的治疗点.
科学领域:
- 类风湿病学 类风湿病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性疾病包括关节,肌肉和骨疾病,如类风湿性关节炎,导致疼痛和残疾.
- 人类微生物群,包括多种微生物,越来越多地被认为在类风湿性疾病的发展中的作用.
- 口腔和肠道微生物群对自身免疫和类风湿性疾病特别感兴趣.
研究的目的:
- 提供有关风湿性疾病口腔和肠道微生物组的当前知识的全面概述.
- 探索微生物向治疗风湿性疾病的潜力.
- 讨论新兴的治疗策略,包括生物信息分析和便移植.
主要方法:
- 审查关于微生物组和类风湿性疾病的当前科学文献.
- 微生物代谢产物的免疫调节性质的分析.
- 探索新的治疗方法,如生物信息分析和便移植.
主要成果:
- 微生物组在类风湿性疾病的发病和进展中发挥着重要作用.
- 微生物代谢产物具有免疫调节性质,可以用于治疗益处.
- 口腔和肠道环境中存在着独特的微生物群落,这些微生物群落会影响宿主健康和疾病.
结论:
- 利用微生物组为开发针对类风湿性疾病的新型治疗策略提供了一个有希望的前沿.
- 进一步研究微生物组与类风湿病之间的复杂关系是有必要的.
- 针对微生物组的新兴治疗方法有可能用于管理自身免疫和类风湿性疾病.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K

